Aiosyn
Nijmegen
About Aiosyn
Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancer and CKD drug development studies for biopharma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: aiosyn.org
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/aiosyn-94511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.